Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Public ClinicalTrials.gov record NCT01198795. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label Long-term Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the long-term safety and tolerability of escitalopram (Lexapro) in children 7 to 11 years of age with major depressive disorder (MDD).
Study identification
- NCT ID
- NCT01198795
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 162 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 7 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2010
- Primary completion
- Dec 31, 2012
- Completion
- Mar 31, 2013
- Last update posted
- Mar 13, 2014
2010 – 2013
United States locations
- U.S. sites
- 16
- U.S. states
- 14
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Forest Investigative Site 001 | Dothan | Alabama | 36303 | — |
| Forest Investigative Site 006 | San Diego | California | 92108 | — |
| Forest Investigative Site 018 | Santa Ana | California | 92701 | — |
| Forest Investigative Site 008 | Washington D.C. | District of Columbia | 20010-2970 | — |
| Forest Investigative Site 013 | Jacksonville Beach | Florida | 32250 | — |
| Forest Investigative Site 017 | Atlanta | Georgia | 30308 | — |
| Forest Investigative Site 004 | Overland Park | Kansas | 66211 | — |
| Forest Investigative Site 011 | Creve Coeur | Missouri | 63141 | — |
| Forest Investigative Site 007 | Omaha | Nebraska | 68131 | — |
| Forest Investigative Site 002 | Cleveland | Ohio | 44106 | — |
| Forest Investigative Site 012 | Oklahoma City | Oklahoma | 73116 | — |
| Forest Investigative Site 003 | Philadelphia | Pennsylvania | 19139 | — |
| Forest Investigative Site 010 | Dallas | Texas | 75235 | — |
| Forest Investigative Site 014 | Clinton | Utah | 84015 | — |
| Forest Investigative Site 005 | Bellevue | Washington | 98007 | — |
| Forest Investigative Site 015 | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01198795, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2014 · Synced Sep 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01198795 live on ClinicalTrials.gov.